Connection
Jonathan Chung to Seminoma
This is a "connection" page, showing publications Jonathan Chung has written about Seminoma.
|
|
Connection Strength |
|
 |
|
 |
|
0.188 |
|
|
|
-
Necchi A, Giannatempo P, Raggi D, Mariani L, Colecchia M, Farè E, Monopoli F, Calareso G, Ali SM, Ross JS, Chung JH, Salvioni R. An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis. Eur Urol. 2019 01; 75(1):201-203.
Score: 0.188